Repligen to buy BioLife Solutions for about USD 1.5 billion, offers USD 31 a share

Reuters2026/07/22 10:02

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Repligen agreed to buy BioLife Solutions in a deal valuing the target at about $1.5 billion.
BioLife holders to receive USD 11.25 cash plus 0.1442 Repligen shares per share, valued at USD 31.
Consideration split: 64% stock, 36% cash; cash portion funded from cash on hand.
Transaction expected to close in Q4 2026, subject to BioLife stockholder vote and customary conditions.
Repligen projects at least USD 20 million synergies in year one, at least USD 30 million in year two.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repligen Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607220600PRIMZONEFULLFEED9766145) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Repligen to buy BioLife Solutions for about USD 1.5 billion, offers USD 31 a share

You may also like

Crypto prices